Skip to main content
. 2019 Apr 30;22(6):372–382. doi: 10.1093/ijnp/pyz008

Figure 3.

Figure 3.

Hippocampus-specific knockdown of peroxisome proliferator-activated receptor δ (PPARδ) decreased hippocampal neurogenesis and neuronal differentiation in mice. (A) Representative micrographs and (B) quantification of 5-Bromo-2’-Deoxyuridine (BrdU)-labeled cells (red) in the dentate gyrus (DG) of the mice. (C) Representative micrographs of cells double-labeled for BrdU (red, left) and the neuronal marker NeuN (green, middle). (D) Percentages of neurons labeled by BrdU in the DG of the mice injected with LV-EGFP or LV-PPARδ-shRNA-EGFP. (E) Representative micrographs of cells double-labeled for BrdU (red, left) and the astrocyte marker glial fibrillary acidic protein (GFAP) (green, middle). (F) Percentages of glial cells labeled by BrdU in the DG of the mice injected with LV-EGFP or LV-PPARδ-shRNA-EGFP. Data shown are mean ± SEM; n = 6. *P < .05, **P < .01 vs control.